{"id":"NCT03069365","sponsor":"AbbVie","briefTitle":"A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment","officialTitle":"A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Renally-Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection (EXPEDITION-5)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-03-28","primaryCompletion":"2018-02-20","completion":"2018-06-05","firstPosted":"2017-03-03","resultsPosted":"2019-03-04","lastUpdate":"2019-03-04"},"enrollment":101,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis C Virus (HCV)"],"interventions":[{"type":"DRUG","name":"Glecaprevir/pibrentasvir","otherNames":["ABT-493/ABT-530","MAVYRET"]}],"arms":[{"label":"GLE/PIB for 8 weeks","type":"EXPERIMENTAL"},{"label":"GLE/PIB for 12 weeks","type":"EXPERIMENTAL"},{"label":"GLE/PIB for 16 weeks","type":"EXPERIMENTAL"}],"summary":"This was a Phase 3b, open-label, non-randomized, multicenter study to evaluate the efficacy and safety of glecaprevir/pibrentasvir (GLE/PIB) in participants with chronic hepatitis C virus (HCV) genotype (GT) 1 - 6 infection without liver cirrhosis or with compensated liver cirrhosis and with chronic renal impairment in participants who were either HCV treatment-na√Øve (TN) or prior treatment-experienced (TE) with interferon (IFN) or pegylated interferon (PegIFN) with or without ribavirin (RBV), or sofosbuvir (SOF) plus RBV with or without pegIFN.","primaryOutcome":{"measure":"Percentage of Participants Achieving Sustained Virologic Response 12 Weeks Post Dosing (SVR12)","timeFrame":"12 weeks after the last actual dose of study drug","effectByArm":[{"arm":"GLE/PIB for 8, 12, or 16 Weeks","deltaMin":97,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":10},"locations":{"siteCount":38,"countries":["United States","Canada","Germany","Greece","Italy","Poland","Puerto Rico","South Korea","Spain","Sweden"]},"refs":{"pmids":["35174470","31821716"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":101},"commonTop":["PRURITUS","PRURITUS GENERALISED","HYPERTENSION"]}}